Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decrement patterns analysis in neuromuscular junction disorders facilitates the early recognition of MuSK-myasthenia gravis. | Neurophysiol Clin | 2025 | 41284500 | PubTator, text mining | PubMed |
| Efgartigimod for generalized myasthenia gravis in the extreme elderly (≥80 years): a multicenter retrospective real-world study. | Front Immunol | 2025 | 41280898 | PubTator, text mining | PubMed |
| Cellular Selectivity Analyses Reveal Distinguishing Profiles for Type II Kinase Inhibitors. | bioRxiv | 2025 | 41278810 | PubTator, text mining | PubMed |
| Anti-ALDOA antibody: a novel diagnostic-associated autoantibody in myasthenia gravis. | Front Neurol | 2025 | 41200447 | PubTator, text mining | PubMed |
| Case Report: Efgartigimod demonstrates significant clinical efficacy in double seropositive myasthenia gravis: a case report of a rare variant and analysis of pathomechanisms. | Front Immunol | 2025 | 41159035 | PubTator, text mining | PubMed |
| Constipation in a Patient With Thymoma: A Diagnostic Mimic of Myasthenia Gravis. | Cureus | 2025 | 41141095 | PubTator, text mining | PubMed |
| Diagnosis of MG and differential diagnoses. | Int Rev Neurobiol | 2025 | 41101823 | PubTator, text mining | PubMed |
| Clarifying the diagnostic utility of decrement patterns in MuSK- and AChR-positive myasthenia gravis. | Neurophysiol Clin | 2025 | 41066833 | PubTator, text mining | PubMed |
| Autoimmune Myasthenia Gravis. | Continuum (Minneap Minn) | 2025 | 41037173 | PubTator, text mining | PubMed |
| Clinical Features and Outcome in Myasthenia Gravis Patients with Antimuscle-specific Tyrosine Kinase Antibody: A Retrospective Study. | Acta Neurol Taiwan | 2025 | 41020460 | PubTator, text mining | PubMed |
| Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now? | Brain Sci | 2025 | 41008338 | PubTator, text mining | PubMed |
| A comparative study of machine learning models on molecular fingerprints for odor decoding. | Commun Chem | 2025 | 40999016 | PubTator, text mining | PubMed |
| Injectable therapeutic system incorporating neurogenesis-programmed stem cells concomitantly promoting muscle regeneration treats stress urinary incontinence. | Nat Commun | 2025 | 40998795 | PubTator, text mining | PubMed |
| Profilin and Non-Canonical Wnt Signaling: Coordinating Cytoskeletal Dynamics from Development to Disease. | J Dev Biol | 2025 | 40981267 | PubTator, text mining | PubMed |
| Surgical management of suspected paraneoplastic myasthenia gravis in rectal cancer during neoadjuvant immunotherapy: a case report. | Front Oncol | 2025 | 40963855 | PubTator, text mining | PubMed |
| Sterilizable autoantigen immobilized column platform for broad-spectrum removal of pathogenic autoantibodies in autoimmune diseases. | J Biosci Bioeng | 2025 | 40912936 | PubTator, text mining | PubMed |
| Sensitivity of Different Clinical Outcome Measures in Assessing Adults With Becker Muscular Dystrophy: A 3-Year Natural History Study. | Neurology | 2025 | 40911807 | PubTator, text mining | PubMed |
| Serum from patients with MuSK antibody-positive myasthenia gravis triggers transcriptomic changes leading to muscle atrophy and weakness in human myotube cells. | J Neuroimmunol | 2025 | 40876077 | PubTator, text mining | PubMed |
| Cauda equina nerve root enhancement in adult intestinal toxemia botulism. | BMC Neurol | 2025 | 40847385 | PubTator, text mining | PubMed |
| Plasma Biomarkers of Mitochondrial Dysfunction in Patients with Myasthenia Gravis. | Med Sci (Basel) | 2025 | 40843740 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=7